LONGEVITY, NUTRITION & WELLNESS

Century invests at the frontier of longevity science and transformative technology — backing the breakthroughs that will extend healthy human life and redefine what it means to grow old.

Aging is not inevitable. We're funding the proof….

Century invests at the frontier of longevity science and transformative technology — backing the breakthroughs that will extend healthy human life and redefine what it means to grow old.

Aging is a system failure. We back the teams fixing it.

Aging begins silently in your 30s with mitochondrial decline, compounding every decade into the conditions that define global chronic disease burden. Addressing aging means addressing the root cause — not managing downstream symptoms. Root cause: mitochondrial dysfunction Mitochondrial function declines ~8–10% per decade with age. This cellular energy deficit drives heart failure, neurodegeneration, metabolic disease, and muscle loss simultaneously — making it the unifying target of longevity medicine.

STRATEGIC FOCUS AREA

DISEASE BURDEN AT SCALE

Brain Disorder

Alzheimer's disease ~55M people globally

Affects 10–16% of people over 60. Linked to mitochondrial dysfunction and cellular energy decline.

Brain Disorder

Parkinson's Disease ~10M people globally

Progressive neurodegeneration with a direct link to mitochondrial pathway failure.

Heart & Metabolic

Heart failure ~64M people globally

Cardiovascular disease is the #1 cause of death worldwide. Energy metabolism at the cellular level is central.

Lung Disease

IPF 3–5 year median survival post-diagnosis

Idiopathic Pulmonary Fibrosis carries poor prognosis. Massive unmet need for disease-modifying therapies.

Five sectors we back

A structured, four-stage framework designed to capture both technology upside and infrastructure-linked stability:

Longevity & healthspan innovations

Science-driven approaches to slow biological aging, prevent age-related decline, and extend productive, healthy years. We back geroscience targeting fundamental mechanisms, not individual disease states.

Nutrition & biotech for global health challenges

Innovative interventions addressing obesity, Type 2 diabetes, and chronic inflammation — affecting over 2.5 billion adults today and projected to impact nearly half the world's population by 2035.

AI-enabled data-to-nutrition & personalised health

Precision solutions powered by biomarkers, genetic intelligence, and real-time physiological data. Platforms that translate complex biology into actionable, individualised guidance at scale.

AgriFood biotech

Next-generation processing, functional ingredients, and sustainable production systems that bridge nutrition science with scalable food technology.

Holistic wellbeing & personal care

Covering personal care to dietary solutions with a focus on mental and physical health integration as inseparable components of longevity.

EVALUATION OF LONGEVITY INVESTMENTS

How we evaluate longevity investments

AI & biomarker intelligence

Advanced analytics and AI-driven diagnostics enabling early detection, precision health insights, and scalable population-level innovation.

Geroscience discovery

Breakthroughs in aging biology and lifespan extension targeting root causes of age-related decline — not symptom management.

Longevity medicine & care delivery

Next-generation healthcare models including preventive care, personalised treatment protocols, and longevity-focused clinical infrastructure.

Community adoption & ecosystem growth

Scalable ecosystems built through consumer engagement, strategic partnerships, and global market expansion to ensure science reaches people.

Work with Century R

For investment enquiries, portfolio partnerships,
or co-investment opportunities.

GET IN TOUCH